查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1365768

心血管数位解决方案市场：按服务、组件和最终用户划分：2023-2032 年全球机会分析和产业预测

Cardiovascular Digital Solutions Market By Service, By Component, By End User : Global Opportunity Analysis and Industry Forecast, 2023-2032
出版日期: | 出版商: Allied Market Research | 英文 255 Pages | 商品交期: 2-3个工作天内

价格

2022年心血管数位解决方案市值为844亿美元，预计2023年至2032年年复合成长率为6.2%，到2032年将达到1541亿美元。

心血管数位解决方案是指旨在解决心血管健康各个方面的基于技术的工具和平台，包括心臟相关疾病的预防、诊断、监测和管理。心血管数位解决方案利用数位技术来加强患者照护、改善结果并为医疗保健专业人员提供有价值的见解。这些解决方案利用行动应用程式、穿戴式装置、远端医疗平台、人工智慧 (AI)、资料分析和远端监控等技术，为心血管疾病患者提供更有效率、更有效的医疗保健服务。

心血管数位解决方案市场-IMG1

心血管数位解决方案市场的推动因素包括高血压、心肌梗塞和中风等心臟疾病的患病不断上升，医疗保健提供者和患者对数位技术的快速采用，以及远端患者监护。心血管疾病患病的上升已成为心血管数位解决方案市场的关键促进因素。心血管疾病，包括冠状动脉疾病、心臟衰竭和中风等疾病，是全世界罹患率和死亡的主要原因。根据美国疾病管制与预防中心的数据，预计 2021 年美国约有 695,000 人死于心臟病。此外，心臟疾病是最常见的心臟病类型，2021 年将导致 375,476 人死亡。传统的心血管护理方法通常依赖定期去医疗机构就诊，这可能不足以进行全面监测和及时干预。另一方面，数位解决方案可以透过穿戴式装置和感测器持续监测心率、血压和氧气水平等生命征象。这种持续监测可以及早发现异常情况和征兆，促进及时介入并降低不利事件的风险。因此，心血管疾病患病的增加预计将成为心血管数位解决方案市场的主要促进因素。

目录

第1章简介

第2章执行摘要

第3章市场概况

  • 市场定义和范围
  • 主要发现
    • 影响要素
    • 主要投资机会
  • 波特五力分析
  • 市场动态
    • 促进因素
      • 心血管疾病患病上升
      • 医疗保健领域数位技术的采用迅速增加
      • 远端患者监护的技术进步
    • 抑制因素
      • 实施成本高
    • 机会
      • 整合到心臟设备中
  • COVID-19 市场影响分析

第4章数位解决方案市场：依服务分类

  • 概述
  • 非侵入性测试
  • 心血管数位健康资讯学
  • 心臟復健计划

第5章心血管数位解决方案市场：按组成部分

  • 概述
  • 装置
  • 软体

第6章心血管数位解决方案市场：依最终用户分类

  • 概述
  • 医疗机构
  • 医疗消费者
  • 其他的

第7章数位解决方案市场：按地区

  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 其他的
  • 亚太地区
    • 日本
    • 中国
    • 澳洲
    • 印度
    • 韩国
    • 其他的
  • 拉丁美洲/中东/非洲
    • 巴西
    • 沙乌地阿拉伯
    • 南非
    • 其他的

第8章竞争形势

  • 介绍
  • 关键成功策略
  • 10家主要企业产品图谱
  • 竞争仪表板
  • 竞争热图
  • 2022年主要企业定位

第9章公司简介

  • iRhythm Technologies, Inc.
  • Apple Inc.
  • General Electric
  • AlivCor, Inc.
  • Verily Life Sciences LLC
  • HeartFlow, Inc
  • Koninklijke Philips NV
  • Cardiac Insight Inc.
  • Baxter International Inc.
  • Murata Manufacturing Co., Ltd.
Product Code: A12468

According to a new report published by Allied Market Research, titled, "Cardiovascular Digital Solutions Market," The cardiovascular digital solutions market was valued at $84.4 billion in 2022, and is estimated to reach $154.1 billion by 2032, growing at a CAGR of 6.2% from 2023 to 2032. Cardiovascular digital solutions refer to technology-based tools and platforms designed to address various aspects of cardiovascular health, including prevention, diagnosis, monitoring, and management of heart-related conditions. Cardiovascular digital solutions leverage digital technologies to enhance patient care, improve outcomes, and provide healthcare professionals with valuable insights. These solutions leverage technology such as mobile apps, wearable devices, telemedicine platforms, artificial intelligence (AI), data analytics, and remote monitoring to provide more efficient and effective healthcare services for individuals with cardiovascular conditions.

Cardiovascular Digital Solutions Market - IMG1

The cardiovascular digital solutions market is driven by rising prevalence of cardiac diseases such as hypertension, cardiac arrythmia, stroke among others, surge in adoption of digital technologies by healthcare providers and patients and technological advancements in remote patient monitoring. The rising prevalence of cardiovascular disease has emerged as a significant driver for the cardiovascular digital solutions market. Cardiovascular disease, including conditions such as coronary artery disease, heart failure, and stroke, continues to be a leading cause of morbidity and mortality worldwide. According to Center for Disease Control and Prevention, in 2021, it was estimated that about 695,000 people in the U.S. died from heart disease. Furthermore, the coronary heart disease is the most common type of heart disease, killing 375,476 people in 2021. Traditional approaches to cardiovascular care often rely on periodic visits to healthcare facilities, which may not be sufficient for comprehensive monitoring and timely intervention. Digital solutions, on the other hand, enable continuous monitoring of vital signs, such as heart rate, blood pressure, and oxygen levels, through wearable devices or sensors. This continuous monitoring allows for early detection of any abnormalities or warning signs, facilitating timely intervention and reducing the risk of adverse events. Thus, the rise in prevalence of cardiovascular disorders is expected to act as a major driver for cardiovascular digital solutions market.

In addition, the rise in adoption of digital technologies such as wearable devices have emerged as a significant driver for the cardiovascular digital solutions market. The integration of advanced digital tools and technologies in the healthcare industry has revolutionized the way cardiovascular diseases are diagnosed, treated, and managed. Furthermore, several hospitals and other healthcare facilities adopted cardiac patches for remote patient monitoring. In March 2021, North Bristol NHS Trust (NBT), a National Health Service, adopted Zio by iRhythm (leading digital health care company) in its cardiology and stroke departments. North Bristol NHS Trust (NBT) evaluated and compared four months of data from cardiology patients using Holter devices pre-Covid with four months of data from patients using Zio patches post-Covid. The evaluation shows that use of the Zio service has resulted in a decrease in waiting times for monitoring. Furthermore, the staff time requirements in the Zio pathway are only 33% as that of the traditional methods (Holter monitors). Thus, the rise in adoption of digital technologies such as wearable devices for cardiac monitoring by healthcare providers and patients is expected to drive the growth of the market.

Furthermore, the technological advancement in remote patient monitoring is expected to drive the growth of the market. For instance, KardiaMobile 6L by AliveCor, a leading medical device, is a portable medical device that enables individuals to monitor their heart health easily and conveniently at home. It is a compact, FDA-cleared, and clinically validated electrocardiogram (EKG) device designed to be used with compatible smartphones or tablets. Thus, the technological advancement in remote patient monitoring leads to better diagnosis and patient monitoring at home, resulting in the growth of the market.

However, high implementation costs of cardiac devices might act as a restraint for the growth of the market. On the other hand, integration of artificial intelligence in cardiac monitoring devices is expected to serve as a growth opportunity in the cardiology digital solutions market.

The cardiovascular digital solutions market is segmented on the basis of service, component, end user and region. By service, the market is categorized into unobtrusive monitoring, CVD health informatics, and cardiac rehabilitation programs. By component, the market is categorized into devices and software. On the basis of end user, the market is categorized into healthcare organization, healthcare consumer, and others. The others include govt institute, payer. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Major key players that operate in the global cardiovascular digital solutions market AlivCor, Inc, Apple Inc., General Electric, Verily Life Sciences LLC, Koninklijke Philips N.V., HeartFlow, Inc, iRhythm Technologies, Inc., Baxter International Inc, Cardiac Insight Inc., and Cardiac Insight Inc.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cardiovascular digital solutions market analysis from 2022 to 2032 to identify the prevailing cardiovascular digital solutions market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the cardiovascular digital solutions market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global cardiovascular digital solutions market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 20% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline talk to the sales executive to know more)

  • Product Benchmarking / Product specification and applications
  • Market share analysis of players by products/segments
  • New Product Development/ Product Matrix of Key Players
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • SWOT Analysis

Key Market Segments

By Service

  • Unobtrusive Testing
  • CVD Health Informatics
  • Cardiac Rehab Programs

By Component

  • Devices
  • Software

By End User

  • Healthcare organization
  • Healthcare consumer
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Verily Life Sciences LLC
    • iRhythm Technologies, Inc.
    • Murata Manufacturing Co., Ltd.
    • Cardiac Insight Inc.
    • Apple Inc.
    • AlivCor, Inc.
    • HeartFlow, Inc
    • Koninklijke Philips N.V.
    • Baxter International Inc.
    • General Electric

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research Methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Low bargaining power of suppliers
    • 3.3.2. Low threat of new entrants
    • 3.3.3. Low threat of substitutes
    • 3.3.4. Low intensity of rivalry
    • 3.3.5. Low bargaining power of buyers
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Rise in prevalence of cardiovascular disorders.
      • 3.4.1.2. Surge in adoption of digital technology in healthcare.
      • 3.4.1.3. Technological advancement in remote patient monitoring.
    • 3.4.2. Restraints
      • 3.4.2.1. High implementation costs
    • 3.4.3. Opportunities
      • 3.4.3.1. Integration of artificial intelligence in cardiac devices
  • 3.5. COVID-19 Impact Analysis on the market

CHAPTER 4: CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY SERVICE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Unobtrusive Testing
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. CVD Health Informatics
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
  • 4.4. Cardiac Rehab Programs
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country

CHAPTER 5: CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY COMPONENT

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Devices
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Software
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country

CHAPTER 6: CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY END USER

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Healthcare organization
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Healthcare consumer
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Others
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country

CHAPTER 7: CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY REGION

  • 7.1. Overview
    • 7.1.1. Market size and forecast By Region
  • 7.2. North America
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by Service
    • 7.2.3. Market size and forecast, by Component
    • 7.2.4. Market size and forecast, by End User
    • 7.2.5. Market size and forecast, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Market size and forecast, by Service
      • 7.2.5.1.2. Market size and forecast, by Component
      • 7.2.5.1.3. Market size and forecast, by End User
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Market size and forecast, by Service
      • 7.2.5.2.2. Market size and forecast, by Component
      • 7.2.5.2.3. Market size and forecast, by End User
      • 7.2.5.3. Mexico
      • 7.2.5.3.1. Market size and forecast, by Service
      • 7.2.5.3.2. Market size and forecast, by Component
      • 7.2.5.3.3. Market size and forecast, by End User
  • 7.3. Europe
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by Service
    • 7.3.3. Market size and forecast, by Component
    • 7.3.4. Market size and forecast, by End User
    • 7.3.5. Market size and forecast, by country
      • 7.3.5.1. Germany
      • 7.3.5.1.1. Market size and forecast, by Service
      • 7.3.5.1.2. Market size and forecast, by Component
      • 7.3.5.1.3. Market size and forecast, by End User
      • 7.3.5.2. France
      • 7.3.5.2.1. Market size and forecast, by Service
      • 7.3.5.2.2. Market size and forecast, by Component
      • 7.3.5.2.3. Market size and forecast, by End User
      • 7.3.5.3. UK
      • 7.3.5.3.1. Market size and forecast, by Service
      • 7.3.5.3.2. Market size and forecast, by Component
      • 7.3.5.3.3. Market size and forecast, by End User
      • 7.3.5.4. Italy
      • 7.3.5.4.1. Market size and forecast, by Service
      • 7.3.5.4.2. Market size and forecast, by Component
      • 7.3.5.4.3. Market size and forecast, by End User
      • 7.3.5.5. Spain
      • 7.3.5.5.1. Market size and forecast, by Service
      • 7.3.5.5.2. Market size and forecast, by Component
      • 7.3.5.5.3. Market size and forecast, by End User
      • 7.3.5.6. Rest of Europe
      • 7.3.5.6.1. Market size and forecast, by Service
      • 7.3.5.6.2. Market size and forecast, by Component
      • 7.3.5.6.3. Market size and forecast, by End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by Service
    • 7.4.3. Market size and forecast, by Component
    • 7.4.4. Market size and forecast, by End User
    • 7.4.5. Market size and forecast, by country
      • 7.4.5.1. Japan
      • 7.4.5.1.1. Market size and forecast, by Service
      • 7.4.5.1.2. Market size and forecast, by Component
      • 7.4.5.1.3. Market size and forecast, by End User
      • 7.4.5.2. China
      • 7.4.5.2.1. Market size and forecast, by Service
      • 7.4.5.2.2. Market size and forecast, by Component
      • 7.4.5.2.3. Market size and forecast, by End User
      • 7.4.5.3. Australia
      • 7.4.5.3.1. Market size and forecast, by Service
      • 7.4.5.3.2. Market size and forecast, by Component
      • 7.4.5.3.3. Market size and forecast, by End User
      • 7.4.5.4. India
      • 7.4.5.4.1. Market size and forecast, by Service
      • 7.4.5.4.2. Market size and forecast, by Component
      • 7.4.5.4.3. Market size and forecast, by End User
      • 7.4.5.5. South Korea
      • 7.4.5.5.1. Market size and forecast, by Service
      • 7.4.5.5.2. Market size and forecast, by Component
      • 7.4.5.5.3. Market size and forecast, by End User
      • 7.4.5.6. Rest of Asia-Pacific
      • 7.4.5.6.1. Market size and forecast, by Service
      • 7.4.5.6.2. Market size and forecast, by Component
      • 7.4.5.6.3. Market size and forecast, by End User
  • 7.5. LAMEA
    • 7.5.1. Key market trends, growth factors and opportunities
    • 7.5.2. Market size and forecast, by Service
    • 7.5.3. Market size and forecast, by Component
    • 7.5.4. Market size and forecast, by End User
    • 7.5.5. Market size and forecast, by country
      • 7.5.5.1. Brazil
      • 7.5.5.1.1. Market size and forecast, by Service
      • 7.5.5.1.2. Market size and forecast, by Component
      • 7.5.5.1.3. Market size and forecast, by End User
      • 7.5.5.2. Saudi Arabia
      • 7.5.5.2.1. Market size and forecast, by Service
      • 7.5.5.2.2. Market size and forecast, by Component
      • 7.5.5.2.3. Market size and forecast, by End User
      • 7.5.5.3. South Africa
      • 7.5.5.3.1. Market size and forecast, by Service
      • 7.5.5.3.2. Market size and forecast, by Component
      • 7.5.5.3.3. Market size and forecast, by End User
      • 7.5.5.4. Rest of LAMEA
      • 7.5.5.4.1. Market size and forecast, by Service
      • 7.5.5.4.2. Market size and forecast, by Component
      • 7.5.5.4.3. Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top player positioning, 2022

CHAPTER 9: COMPANY PROFILES

  • 9.1. iRhythm Technologies, Inc.
    • 9.1.1. Company overview
    • 9.1.2. Key Executives
    • 9.1.3. Company snapshot
    • 9.1.4. Operating business segments
    • 9.1.5. Product portfolio
    • 9.1.6. Business performance
  • 9.2. Apple Inc.
    • 9.2.1. Company overview
    • 9.2.2. Key Executives
    • 9.2.3. Company snapshot
    • 9.2.4. Operating business segments
    • 9.2.5. Product portfolio
    • 9.2.6. Business performance
  • 9.3. General Electric
    • 9.3.1. Company overview
    • 9.3.2. Key Executives
    • 9.3.3. Company snapshot
    • 9.3.4. Operating business segments
    • 9.3.5. Product portfolio
    • 9.3.6. Business performance
    • 9.3.0. Key strategic moves and developments
  • 9.4. AlivCor, Inc.
    • 9.4.1. Company overview
    • 9.4.2. Key Executives
    • 9.4.3. Company snapshot
    • 9.4.4. Operating business segments
    • 9.4.5. Product portfolio
    • 9.4.0. Key strategic moves and developments
  • 9.5. Verily Life Sciences LLC
    • 9.5.1. Company overview
    • 9.5.2. Key Executives
    • 9.5.3. Company snapshot
    • 9.5.4. Operating business segments
    • 9.5.5. Product portfolio
  • 9.6. HeartFlow, Inc
    • 9.6.1. Company overview
    • 9.6.2. Key Executives
    • 9.6.3. Company snapshot
    • 9.6.4. Operating business segments
    • 9.6.5. Product portfolio
    • 9.6.0. Key strategic moves and developments
  • 9.7. Koninklijke Philips N.V.
    • 9.7.1. Company overview
    • 9.7.2. Key Executives
    • 9.7.3. Company snapshot
    • 9.7.4. Operating business segments
    • 9.7.5. Product portfolio
    • 9.7.6. Business performance
    • 9.7.0. Key strategic moves and developments
  • 9.8. Cardiac Insight Inc.
    • 9.8.1. Company overview
    • 9.8.2. Key Executives
    • 9.8.3. Company snapshot
    • 9.8.4. Operating business segments
    • 9.8.5. Product portfolio
    • 9.8.0. Key strategic moves and developments
  • 9.9. Baxter International Inc.
    • 9.9.1. Company overview
    • 9.9.2. Key Executives
    • 9.9.3. Company snapshot
    • 9.9.4. Operating business segments
    • 9.9.5. Product portfolio
    • 9.9.6. Business performance
    • 9.9.0. Key strategic moves and developments
  • 9.10. Murata Manufacturing Co., Ltd.
    • 9.10.1. Company overview
    • 9.10.2. Key Executives
    • 9.10.3. Company snapshot
    • 9.10.4. Operating business segments
    • 9.10.5. Product portfolio
    • 9.10.6. Business performance

LIST OF TABLES

  • TABLE 01. GLOBAL CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 02. CARDIOVASCULAR DIGITAL SOLUTIONS MARKET FOR UNOBTRUSIVE TESTING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 03. CARDIOVASCULAR DIGITAL SOLUTIONS MARKET FOR CVD HEALTH INFORMATICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 04. CARDIOVASCULAR DIGITAL SOLUTIONS MARKET FOR CARDIAC REHAB PROGRAMS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 05. GLOBAL CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 06. CARDIOVASCULAR DIGITAL SOLUTIONS MARKET FOR DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 07. CARDIOVASCULAR DIGITAL SOLUTIONS MARKET FOR SOFTWARE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 08. GLOBAL CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 09. CARDIOVASCULAR DIGITAL SOLUTIONS MARKET FOR HEALTHCARE ORGANIZATION, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. CARDIOVASCULAR DIGITAL SOLUTIONS MARKET FOR HEALTHCARE CONSUMER, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. CARDIOVASCULAR DIGITAL SOLUTIONS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. NORTH AMERICA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 14. NORTH AMERICA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 15. NORTH AMERICA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 16. NORTH AMERICA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 17. U.S. CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 18. U.S. CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 19. U.S. CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 20. CANADA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 21. CANADA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 22. CANADA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 23. MEXICO CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 24. MEXICO CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 25. MEXICO CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 26. EUROPE CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 27. EUROPE CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 28. EUROPE CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 29. EUROPE CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 30. GERMANY CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 31. GERMANY CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 32. GERMANY CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 33. FRANCE CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 34. FRANCE CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 35. FRANCE CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 36. UK CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 37. UK CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 38. UK CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 39. ITALY CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 40. ITALY CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 41. ITALY CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 42. SPAIN CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 43. SPAIN CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 44. SPAIN CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 45. REST OF EUROPE CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 46. REST OF EUROPE CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 47. REST OF EUROPE CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 48. ASIA-PACIFIC CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 49. ASIA-PACIFIC CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 50. ASIA-PACIFIC CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 51. ASIA-PACIFIC CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 52. JAPAN CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 53. JAPAN CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 54. JAPAN CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 55. CHINA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 56. CHINA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 57. CHINA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 58. AUSTRALIA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 59. AUSTRALIA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 60. AUSTRALIA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 61. INDIA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 62. INDIA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 63. INDIA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 64. SOUTH KOREA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 65. SOUTH KOREA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 66. SOUTH KOREA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 67. REST OF ASIA-PACIFIC CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 68. REST OF ASIA-PACIFIC CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 69. REST OF ASIA-PACIFIC CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 70. LAMEA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 71. LAMEA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 72. LAMEA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 73. LAMEA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 74. BRAZIL CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 75. BRAZIL CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 76. BRAZIL CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 77. SAUDI ARABIA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 78. SAUDI ARABIA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 79. SAUDI ARABIA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 80. SOUTH AFRICA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 81. SOUTH AFRICA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 82. SOUTH AFRICA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 83. REST OF LAMEA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY SERVICE, 2022-2032 ($MILLION)
  • TABLE 84. REST OF LAMEA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 85. REST OF LAMEA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 86. IRHYTHM TECHNOLOGIES, INC.: KEY EXECUTIVES
  • TABLE 87. IRHYTHM TECHNOLOGIES, INC.: COMPANY SNAPSHOT
  • TABLE 88. IRHYTHM TECHNOLOGIES, INC.: PRODUCT SEGMENTS
  • TABLE 89. IRHYTHM TECHNOLOGIES, INC.: SERVICE SEGMENTS
  • TABLE 90. IRHYTHM TECHNOLOGIES, INC.: PRODUCT PORTFOLIO
  • TABLE 91. APPLE INC.: KEY EXECUTIVES
  • TABLE 92. APPLE INC.: COMPANY SNAPSHOT
  • TABLE 93. APPLE INC.: PRODUCT SEGMENTS
  • TABLE 94. APPLE INC.: PRODUCT PORTFOLIO
  • TABLE 95. GENERAL ELECTRIC: KEY EXECUTIVES
  • TABLE 96. GENERAL ELECTRIC: COMPANY SNAPSHOT
  • TABLE 97. GENERAL ELECTRIC: SERVICE SEGMENTS
  • TABLE 98. GENERAL ELECTRIC: PRODUCT PORTFOLIO
  • TABLE 99. GENERAL ELECTRIC: KEY STRATERGIES
  • TABLE 100. ALIVCOR, INC.: KEY EXECUTIVES
  • TABLE 101. ALIVCOR, INC.: COMPANY SNAPSHOT
  • TABLE 102. ALIVCOR, INC.: PRODUCT SEGMENTS
  • TABLE 103. ALIVCOR, INC.: PRODUCT PORTFOLIO
  • TABLE 104. ALIVCOR, INC.: KEY STRATERGIES
  • TABLE 105. VERILY LIFE SCIENCES LLC: KEY EXECUTIVES
  • TABLE 106. VERILY LIFE SCIENCES LLC: COMPANY SNAPSHOT
  • TABLE 107. VERILY LIFE SCIENCES LLC: PRODUCT SEGMENTS
  • TABLE 108. VERILY LIFE SCIENCES LLC: PRODUCT PORTFOLIO
  • TABLE 109. HEARTFLOW, INC: KEY EXECUTIVES
  • TABLE 110. HEARTFLOW, INC: COMPANY SNAPSHOT
  • TABLE 111. HEARTFLOW, INC: PRODUCT SEGMENTS
  • TABLE 112. HEARTFLOW, INC: PRODUCT PORTFOLIO
  • TABLE 113. HEARTFLOW, INC: KEY STRATERGIES
  • TABLE 114. KONINKLIJKE PHILIPS N.V.: KEY EXECUTIVES
  • TABLE 115. KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
  • TABLE 116. KONINKLIJKE PHILIPS N.V.: PRODUCT SEGMENTS
  • TABLE 117. KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO
  • TABLE 118. KONINKLIJKE PHILIPS N.V.: KEY STRATERGIES
  • TABLE 119. CARDIAC INSIGHT INC.: KEY EXECUTIVES
  • TABLE 120. CARDIAC INSIGHT INC.: COMPANY SNAPSHOT
  • TABLE 121. CARDIAC INSIGHT INC.: PRODUCT SEGMENTS
  • TABLE 122. CARDIAC INSIGHT INC.: PRODUCT PORTFOLIO
  • TABLE 123. CARDIAC INSIGHT INC.: KEY STRATERGIES
  • TABLE 124. BAXTER INTERNATIONAL INC.: KEY EXECUTIVES
  • TABLE 125. BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT
  • TABLE 126. BAXTER INTERNATIONAL INC.: PRODUCT SEGMENTS
  • TABLE 127. BAXTER INTERNATIONAL INC.: PRODUCT PORTFOLIO
  • TABLE 128. BAXTER INTERNATIONAL INC.: KEY STRATERGIES
  • TABLE 129. MURATA MANUFACTURING CO., LTD.: KEY EXECUTIVES
  • TABLE 130. MURATA MANUFACTURING CO., LTD.: COMPANY SNAPSHOT
  • TABLE 131. MURATA MANUFACTURING CO., LTD.: PRODUCT SEGMENTS
  • TABLE 132. MURATA MANUFACTURING CO., LTD.: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01. CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, 2022-2032
  • FIGURE 02. SEGMENTATION OF CARDIOVASCULAR DIGITAL SOLUTIONS MARKET,2022-2032
  • FIGURE 03. TOP INVESTMENT POCKETS IN CARDIOVASCULAR DIGITAL SOLUTIONS MARKET (2023-2032)
  • FIGURE 04. LOW BARGAINING POWER OF SUPPLIERS
  • FIGURE 05. LOW THREAT OF NEW ENTRANTS
  • FIGURE 06. LOW THREAT OF SUBSTITUTES
  • FIGURE 07. LOW INTENSITY OF RIVALRY
  • FIGURE 08. LOW BARGAINING POWER OF BUYERS
  • FIGURE 09. GLOBAL CARDIOVASCULAR DIGITAL SOLUTIONS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 10. CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY SERVICE, 2022(%)
  • FIGURE 11. COMPARATIVE SHARE ANALYSIS OF CARDIOVASCULAR DIGITAL SOLUTIONS MARKET FOR UNOBTRUSIVE TESTING, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF CARDIOVASCULAR DIGITAL SOLUTIONS MARKET FOR CVD HEALTH INFORMATICS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 13. COMPARATIVE SHARE ANALYSIS OF CARDIOVASCULAR DIGITAL SOLUTIONS MARKET FOR CARDIAC REHAB PROGRAMS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 14. CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY COMPONENT, 2022(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF CARDIOVASCULAR DIGITAL SOLUTIONS MARKET FOR DEVICES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF CARDIOVASCULAR DIGITAL SOLUTIONS MARKET FOR SOFTWARE, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 17. CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, BY END USER, 2022(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF CARDIOVASCULAR DIGITAL SOLUTIONS MARKET FOR HEALTHCARE ORGANIZATION, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF CARDIOVASCULAR DIGITAL SOLUTIONS MARKET FOR HEALTHCARE CONSUMER, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF CARDIOVASCULAR DIGITAL SOLUTIONS MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 21. CARDIOVASCULAR DIGITAL SOLUTIONS MARKET BY REGION, 2022(%)
  • FIGURE 22. U.S. CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, 2022-2032 ($MILLION)
  • FIGURE 23. CANADA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, 2022-2032 ($MILLION)
  • FIGURE 24. MEXICO CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, 2022-2032 ($MILLION)
  • FIGURE 25. GERMANY CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, 2022-2032 ($MILLION)
  • FIGURE 26. FRANCE CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, 2022-2032 ($MILLION)
  • FIGURE 27. UK CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, 2022-2032 ($MILLION)
  • FIGURE 28. ITALY CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, 2022-2032 ($MILLION)
  • FIGURE 29. SPAIN CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, 2022-2032 ($MILLION)
  • FIGURE 30. REST OF EUROPE CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, 2022-2032 ($MILLION)
  • FIGURE 31. JAPAN CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, 2022-2032 ($MILLION)
  • FIGURE 32. CHINA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, 2022-2032 ($MILLION)
  • FIGURE 33. AUSTRALIA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, 2022-2032 ($MILLION)
  • FIGURE 34. INDIA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, 2022-2032 ($MILLION)
  • FIGURE 35. SOUTH KOREA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, 2022-2032 ($MILLION)
  • FIGURE 36. REST OF ASIA-PACIFIC CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, 2022-2032 ($MILLION)
  • FIGURE 37. BRAZIL CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, 2022-2032 ($MILLION)
  • FIGURE 38. SAUDI ARABIA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, 2022-2032 ($MILLION)
  • FIGURE 39. SOUTH AFRICA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, 2022-2032 ($MILLION)
  • FIGURE 40. REST OF LAMEA CARDIOVASCULAR DIGITAL SOLUTIONS MARKET, 2022-2032 ($MILLION)
  • FIGURE 41. TOP WINNING STRATEGIES, BY YEAR (2020-2023)
  • FIGURE 42. TOP WINNING STRATEGIES, BY DEVELOPMENT (2020-2023)
  • FIGURE 43. TOP WINNING STRATEGIES, BY COMPANY (2020-2023)
  • FIGURE 44. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 45. COMPETITIVE DASHBOARD
  • FIGURE 46. COMPETITIVE HEATMAP: CARDIOVASCULAR DIGITAL SOLUTIONS MARKET
  • FIGURE 47. TOP PLAYER POSITIONING, 2022
  • FIGURE 48. IRHYTHM TECHNOLOGIES, INC.: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 49. APPLE INC.: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 50. APPLE INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 51. APPLE INC.: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 52. GENERAL ELECTRIC: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 53. GENERAL ELECTRIC: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 54. GENERAL ELECTRIC: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 55. KONINKLIJKE PHILIPS N.V.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 56. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 57. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 58. BAXTER INTERNATIONAL INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 59. BAXTER INTERNATIONAL INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 60. BAXTER INTERNATIONAL INC.: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 61. MURATA MANUFACTURING CO., LTD.: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 62. MURATA MANUFACTURING CO., LTD.: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 63. MURATA MANUFACTURING CO., LTD.: REVENUE SHARE BY SEGMENT, 2021 (%)